Researchers report that declining PPP2R5C levels in blood may signal early Alzheimer’s pathology, offering new insight into tau regulation and future diagnostic strategies
Study: Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease
In a recent study published in the journal Cell Reports Medicine, researchers identified protein phosphatase 2 regulatory subunit B’β (PPP2R5C) as a potential early biomarker associated with Alzheimer’s disease (AD).
Alzheimer’s Disease Pathology and the Need for Early Biomarkers
AD is the most common form of dementia and disproportionately affects the aging population. Pathological changes in AD begin decades before symptom onset, highlighting the importance of identifying reliable early biomarkers to enable…